Revenue Growth Acceleration
CME Group's total revenue reached $1.88B in Q1 2026, up 14.5% from $1.64B in Q1 2025, reflecting strong demand for derivatives and risk management products across asset classes in a volatile macro environment.
CME GROUP INC. is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: CME Group delivered a strong Q1 2026 with revenue rising 14.5% YoY to $1.88B and operating income surging 18.2% to $1.31B, driven by robust trading volumes and an industry-leading operating margin of nearly 70%.
Drawn from management commentary in the Q1 2026 10-Q:
CME Group's total revenue reached $1.88B in Q1 2026, up 14.5% from $1.64B in Q1 2025, reflecting strong demand for derivatives and risk management products across asset classes in a volatile macro environment.
Operating income grew 18.2% YoY to $1.31B, outpacing revenue growth and expanding the operating margin to approximately 69.7% from 67.5% a year ago — a 220 basis point improvement that underscores CME's highly scalable business model.
Basic EPS jumped 23.6% YoY to $3.25 (diluted EPS up 21.4% to $3.18), reflecting both earnings growth and the benefit of share count management, delivering meaningful value to shareholders.
Revenue
$1.88B
++14.48% YoY
EPS (Basic)
$3.25
++23.57% YoY
Operating Income
$1.31B
++18.20% YoY
Add CME to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.